Biotechnology VALUE FUND L P, 10% Owner, Director, Ten Percent Owner Other at Rain Therapeutics Inc. (RAIN), bought 1,010,908 shares at $15.65 ($15.7M) on 2021-07-01, disclosed to the SEC on 2021-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.65 | 20,018 | $313K | 2.0% |
| 2 | $15.65 | 20,018 | $313K | 2.0% |
| 3 | $15.65 | 124,804 | $2.0M | 12.5% |
| 4 | $15.65 | 124,804 | $2.0M | 12.5% |
| 5 | $15.65 | 172,457 | $2.7M | 17.2% |
| 6 | $15.65 | 172,457 |
| $2.7M |
| 17.2% |
| 7 | $15.25 | 16,980 | $259K | 1.7% |
| 8 | $15.25 | 106,627 | $1.6M | 10.4% |
| 9 | $15.25 | 106,627 | $1.6M | 10.4% |
| 10 | $15.25 | 146,116 | $2.2M | 14.2% |
| Total | $15.50 avg | 1,010,908 | $15.7M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |